EX-99.1 2 d142579dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

PRESS RELEASE

INVESTOR CONTACT:

Lisa L. Ewbank

Synopsys, Inc.

650-584-1901

Synopsys-ir@synopsys.com

EDITORIAL CONTACT:

Simone Souza

Synopsys, Inc.

650-584-6454

simone@synopsys.com

Synopsys Posts Financial Results for First Quarter Fiscal Year 2021

Q1 2021 Financial Highlights

 

   

Revenue: $970.3 million

 

   

GAAP earnings per share: $1.03

 

   

Non-GAAP earnings per share: $1.52

MOUNTAIN VIEW, Calif. Feb. 17, 2021Synopsys, Inc. (Nasdaq: SNPS) today reported results for its first quarter fiscal year 2021. Revenue for the first quarter was $970.3 million, compared to $834.4 million for the first quarter of fiscal 2020.

“The first quarter was a very good start to fiscal year 2021, with strength across all geographies and product groups. We delivered financial results at or above guidance targets, initiated a $250 million stock repurchase, and are reaffirming our outlook for the year,” said Aart de Geus, chairman and co-CEO of Synopsys. “Our markets are strong, as companies across vertical segments are racing to leverage big data, faster computation, and machine learning to differentiate themselves. Synopsys is at the heart of this wave of advanced technology. Our highly differentiated portfolio of solutions, including exciting new innovations in EDA, state-of-the-art IP blocks and leading software security products and services, is generating high demand and excellent growth. In fiscal 2021, we expect to deliver low-to-mid teens non-GAAP earnings per share growth on revenue surpassing the $4 billion milestone and continued non-GAAP operating margin expansion, with more than $1 billion in operating cash flow.”


GAAP Results

On a generally accepted accounting principles (GAAP) basis, net income for the first quarter of fiscal 2021 was $162.3 million, or $1.03 per share, compared to $104.1 million, or $0.67 per share, for the first quarter of fiscal 2020.

Non-GAAP Results

On a non-GAAP basis, net income for the first quarter of fiscal 2021 was $239.5 million, or $1.52 per share, compared to non-GAAP net income of $156.7 million, or $1.01 per share, for the first quarter of fiscal 2020.

For a reconciliation between GAAP and non-GAAP results, see “GAAP to Non-GAAP Reconciliation” and the accompanying tables below.

Business Segments

Synopsys reports revenue and operating income in two segments: (1) Semiconductor & System Design, which includes EDA tools, IP products, system integration solutions and associated services, and (2) Software Integrity, which includes security and quality solutions for software development across many industries. Further information regarding these segments is provided at the end of this press release.

Financial Targets

Synopsys also provided its consolidated financial targets for the second quarter and full fiscal year 2021. These financial targets assume that there are no further changes to the current U.S. government “Entity List” restrictions for the rest of the fiscal year. These targets constitute forward-looking statements and are based on current expectations. For a discussion of factors that could cause actual results to differ materially from these targets, see “Forward-Looking Statements” below.


Second Quarter and Fiscal Year 2021 Financial Targets

(in millions except per share amounts)

 

     Q2 FY 2021     FY 2021  
     Low     High     Low     High  

Revenue

   $ 970     $ 1,000     $ 4,000     $ 4,050  

GAAP Expenses

   $ 801     $ 819     $ 3,234     $ 3,279  

Non-GAAP Expenses

   $ 697     $ 707     $ 2,825     $ 2,855  

Other Income (Expense)

   $ (4   $ (2   $ (11   $ (7

Normalized Annual Tax Rate (1)

     16     16     16     16

Outstanding Shares (fully diluted)

     156       159       156       159  

GAAP EPS

   $ 0.93     $ 1.02     $ 4.29     $ 4.45  

Non-GAAP EPS

   $ 1.50     $ 1.55     $ 6.23     $ 6.30  

Operating Cash Flow

       $ 1,200     $ 1,300  

 

(1)

Applied in non-GAAP net income calculations

Earnings Call Open to Investors

Synopsys will hold a conference call for financial analysts and investors today at 2:00 p.m. Pacific Time. A live webcast of the call will be available on Synopsys’ corporate website at www.synopsys.com. A recording of the call will be available by calling +1-866-207-1041 (+1-402-970-0847 for international callers), access code 9968053, beginning at 5:00 p.m. Pacific Time today, until 11:59 p.m. Pacific Time on February 24, 2021. A webcast replay will also be available on the website from approximately 5:30 p.m. Pacific Time today through the time Synopsys announces its results for the second quarter of fiscal year 2021 in May 2021. Synopsys will post copies of the prepared remarks of Aart de Geus, chairman and co-chief executive officer, and Trac Pham, chief financial officer, on its website following today’s call. In addition, Synopsys makes additional information available in a financial supplement and corporate overview presentation, also posted on the corporate website.

Effectiveness of Information

The targets included in this press release, the statements made during the earnings conference call and the information contained in the financial supplement and corporate overview presentation (available in the Investor Relations section of Synopsys’ corporate website at www.synopsys.com) represent Synopsys’ expectations and beliefs as of the date of this release only. Although this press release, copies of the prepared remarks of the co-chief executive officer and chief financial officer made during the call, the financial supplement, and the corporate overview presentation will remain available on Synopsys’ website through the date of


the second quarter fiscal year 2021 earnings call in May 2021, their continued availability through such date does not mean that Synopsys is reaffirming or confirming their continued validity. Synopsys does not currently intend to report on its progress during the second quarter of fiscal year 2021 or comment to analysts or investors on, or otherwise update, the targets given in this release.

Availability of Final Financial Statements

Synopsys will include final financial statements for the first quarter fiscal year 2021 in its quarterly report on Form 10-Q to be filed by March 11, 2021.

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Software partner for innovative companies developing the electronic products and software applications we rely on every day. As an S&P 500 company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and offers the industry’s broadest portfolio of application security testing tools and services. Whether you’re a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing more secure, high-quality code, Synopsys has the solutions needed to deliver innovative products. Learn more at www.synopsys.com.

GAAP to Non-GAAP Reconciliation

Synopsys continues to provide all information required in accordance with GAAP but believes evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, Synopsys presents non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Synopsys’ operating results in a manner that focuses on what Synopsys believes to be its core business operations and what Synopsys uses to evaluate its business operations and for internal planning and forecasting purposes. Synopsys’ management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Synopsys’ management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes: (i) the amortization of acquired intangible assets, (ii) the impact of stock compensation, (iii) acquisition-related costs, (iv) restructuring charges, (v) the effects of certain settlements, final judgments and loss contingencies related to legal proceedings, and (vi) the income tax effect of non-GAAP pre-tax adjustments; and the non-GAAP measures that exclude such information in order to assess the performance of Synopsys’ business and for planning and forecasting in subsequent periods.


Synopsys utilizes a normalized annual non-GAAP tax rate in the calculation of its non-GAAP measures to provide better consistency across interim reporting periods by eliminating the effects of non-recurring and period-specific items such as tax audit settlements, which can vary in size and frequency and not necessarily reflect our normal operations, and to more clearly align our tax rate with our expected geographic earnings mix. In projecting this rate, we evaluate our historical and projected mix of U.S. and international profit before tax, excluding the non-GAAP adjustments described above. We also consider other factors including our current tax structure, our existing tax positions, and expected recurring tax incentives. On an annual basis, we re-evaluate this rate for significant events, including changes in tax laws and regulations, that may materially affect our projections. Based upon our review, our projected normalized annual non-GAAP tax rate remains 16% through fiscal year 2021.

Whenever Synopsys uses a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed below, as well as Item 2.02 of the Current Report on Form 8-K filed on February 17, 2021 for additional information about the measures Synopsys uses to evaluate its core business operations.


Reconciliation of First Quarter Fiscal Year 2021 Results

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP net income and earnings per share for the periods indicated below.

GAAP to Non-GAAP Reconciliation of First Quarter Fiscal Year 2021 Results (1)

(unaudited and in thousands, except per share amounts)

 

                                 
     Three Months Ended
January 31,
 
     2021      2020  

GAAP net income

   $ 162,345      $ 104,061  

Adjustments:

     

Amortization of intangible assets

     20,276        22,533  

Stock compensation

     83,782        51,883  

Acquisition-related costs

     3,548        3,777  

Restructuring charges

     —          8,751  

Tax adjustments

     (30,478      (34,331
  

 

 

    

 

 

 

Non-GAAP net income

   $ 239,473      $ 156,674  
  

 

 

    

 

 

 

 

     Three Months Ended
January 31,
 
     2021      2020  

GAAP diluted net income per share

   $ 1.03      $ 0.67  

Adjustments:

     

Amortization of intangible assets

     0.13        0.15  

Stock compensation

     0.53        0.34  

Acquisition-related costs

     0.02        0.02  

Restructuring charges

     —          0.06  

Tax adjustments

     (0.19      (0.23
  

 

 

    

 

 

 

Non-GAAP diluted net income per share

   $ 1.52      $ 1.01  
  

 

 

    

 

 

 

Shares used in computing diluted net income per share amounts:

     157,277        154,504  

 

(1)

Synopsys’ first quarter of fiscal year 2021 and 2020 ended on January 30, 2021 and February 1, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.


Reconciliation of 2021 Targets

The following tables reconcile the specific items excluded from GAAP in the calculation of non-GAAP targets for the periods indicated below.

GAAP to Non-GAAP Reconciliation of Second Quarter Fiscal Year 2021 Targets (1)

(in thousands, except per share amounts)

 

                                 
     Range for Three Months
April 30, 2021
 
         Low              High      

Target GAAP expenses

   $ 801,000      $ 819,000  

Adjustments:

     

Estimated impact of amortization of intangible assets

     (19,000      (22,000

Estimated impact of stock compensation

     (85,000      (90,000
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 697,000      $ 707,000  
  

 

 

    

 

 

 

 

     Range for Three Months
April 30, 2021
 
     Low      High  

Target GAAP earnings per share

   $ 0.93      $ 1.02  

Adjustments:

     

Estimated impact of amortization of intangible assets

     0.14        0.12  

Estimated impact of stock compensation

     0.57        0.54  

Estimated impact of tax adjustments

     (0.14      (0.13
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 1.50      $ 1.55  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,500        157,500  

GAAP to Non-GAAP Reconciliation of Full Fiscal Year 2021 Targets (1)

(in thousands, except per share amounts)

 

     Range for Fiscal Year
October 31, 2021
 
     Low      High  

Target GAAP expenses

   $ 3,233,548      $ 3,278,548  

Adjustments:

     

Estimated impact of amortization of intangible assets

     (75,000      (80,000

Estimated impact of stock compensation

     (330,000      (340,000

Acquisition-related costs

     (3,548      (3,548
  

 

 

    

 

 

 

Target non-GAAP expenses

   $ 2,825,000      $ 2,855,000  
  

 

 

    

 

 

 

 

     Range for Fiscal Year  
     October 31, 2021  
     Low      High  

Target GAAP earnings per share

   $ 4.29      $ 4.45  

Adjustments:

     

Estimated impact of amortization of intangible assets

     0.51        0.48  

Estimated impact of stock compensation

     2.16        2.10  

Acquisition-related costs

     0.02        0.02  

Estimated impact of tax adjustments

     (0.75      (0.75
  

 

 

    

 

 

 

Target non-GAAP earnings per share

   $ 6.23      $ 6.30  
  

 

 

    

 

 

 

Shares used in non-GAAP calculation (midpoint of target range)

     157,500        157,500  

 

(1)

Synopsys’ second fiscal quarter and fiscal year will end on May 1, 2021 and October 30, 2021, respectively. For presentation purposes, we refer to the closest calendar month end.


Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, statements regarding Synopsys’ short-term and long-term financial targets, expectations and objectives; business outlook, opportunities and strategies; customer demand and market expansion; strategies related to our products and technology; our planned product releases and capabilities; industry growth rates; software trends; planned acquisitions and buybacks; our expected tax rate; the expected impact of U.S. and foreign government action on our results; and the expected impact of the COVID-19 pandemic. These statements involve risks, uncertainties and other factors that could cause our actual results, time frames or achievements to differ materially from those expressed or implied in our forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks from the effect of the COVID-19 pandemic and the associated economic downturn on our business, operations and financial condition; uncertainty in the growth of the semiconductor and electronics industries; consolidation among our customers and our dependence on a relatively small number of large customers; risks and compliance obligations relating to the global nature of our operations as well as actions by the U.S. or foreign governments, such as measures in response to the COVID-19 pandemic or the imposition of additional tariffs or export restrictions; macroeconomic conditions and uncertainty in the global economy; fluctuation of our operating results; increased variability in our revenue due to the adoption of ASC 606, including the resulting increase in recognizing upfront revenue as a percentage of total revenue; and more. Additional information on potential risks, uncertainties and other factors that could affect Synopsys’ results is included in filings it makes with the Securities and Exchange Commission from time to time, including in the sections entitled “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended October 31, 2020 and its latest Quarterly Report on Form 10-Q. The information provided herein is as of February 17, 2021. Synopsys undertakes no duty, and does not intend to update any forward-looking statement, whether as a result of new information, future events or otherwise, unless required by law.

###


SYNOPSYS, INC.

Unaudited Consolidated Statements of Operations (1)

(in thousands, except per share amounts)

 

     Three Months Ended  
     January 31,  
     2021     2020  

Revenue:

    

Time-based products

   $  631,290     $  556,439  

Upfront products

     174,381       150,721  

Maintenance and service

     164,650       127,221  
  

 

 

   

 

 

 

Total revenue

     970,321       834,381  

Cost of revenue:

    

Products

     127,347       117,784  

Maintenance and service

     68,766       61,915  

Amortization of intangible assets

     11,886       13,169  
  

 

 

   

 

 

 

Total cost of revenue

     207,999       192,868  
  

 

 

   

 

 

 

Gross margin

     762,322       641,513  

Operating expenses:

    

Research and development

     357,468       314,283  

Sales and marketing

     170,628       152,855  

General and administrative

     77,488       68,744  

Amortization of intangible assets

     8,390       9,364  

Restructuring charges

     —         8,751  
  

 

 

   

 

 

 

Total operating expenses

     613,974       553,997  
  

 

 

   

 

 

 

Operating income

     148,348       87,516  

Other income (expense), net

     28,756       12,057  
  

 

 

   

 

 

 

Income before income taxes

     177,104       99,573  

Provision (benefit) for income taxes

     15,076       (4,488
  

 

 

   

 

 

 

Net income

     162,028       104,061  

Net income (loss) attributed to non-controlling interest

     (317     —    
  

 

 

   

 

 

 

Net income attributed to Synopsys

   $ 162,345     $ 104,061  
  

 

 

   

 

 

 

Net income per share:

    

Basic

   $ 1.06     $ 0.69  

Diluted

   $ 1.03     $ 0.67  

Shares used in computing per share amounts:

    

Basic

     152,498       150,244  
  

 

 

   

 

 

 

Diluted

     157,277       154,504  
  

 

 

   

 

 

 

 

(1)

Synopsys’ first quarter of fiscal year 2021 and 2020 ended on January 30, 2021 and February 1, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.


SYNOPSYS, INC.

Unaudited Consolidated Balance Sheets (1)

(in thousands, except par value amounts)

 

     January 31, 2021     October 31, 2020  

ASSETS:

    

Current assets:

    

Cash and cash equivalents

   $ 1,023,074     $ 1,235,653  

Accounts receivable, net

     789,320       780,709  

Inventories, net

     230,907       192,333  

Income taxes receivable and prepaid taxes

     25,190       32,355  

Prepaid and other current assets

     329,233       308,167  
  

 

 

   

 

 

 

Total current assets

     2,397,724       2,549,217  

Property and equipment, net

     486,604       483,818  

Operating lease right-of-use assets, net

     462,136       465,818  

Goodwill

     3,433,003       3,365,114  

Intangible assets, net

     254,375       254,322  

Long-term prepaid taxes

     8,285       8,276  

Deferred income taxes

     522,871       497,546  

Other long-term assets

     447,840       405,951  
  

 

 

   

 

 

 

Total assets

   $ 8,012,838     $ 8,030,062  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY:

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 422,928     $ 623,664  

Operating lease liabilities, current

     72,769       73,173  

Accrued income taxes

     32,227       27,738  

Deferred revenue

     1,546,038       1,388,263  

Short-term debt

     97,421       27,084  
  

 

 

   

 

 

 

Total current liabilities

     2,171,383       2,139,922  

Operating lease liabilities, non-current

     459,880       462,411  

Long-term accrued income taxes

     25,184       25,178  

Long-term deferred revenue

     107,001       104,850  

Long-term debt

     25,658       100,823  

Other long-term liabilities

     336,834       284,511  
  

 

 

   

 

 

 

Total liabilities

     3,125,940       3,117,695  

Stockholders’ equity:

    

Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding

     —         —    

Common stock, $0.01 par value: 400,000 shares authorized; 152,364 and 152,618 shares outstanding, respectively

     1,526       1,528  

Capital in excess of par value

     1,589,175       1,653,166  

Retained earnings

     3,954,542       3,795,397  

Treasury stock, at cost: 4,897 and 4,643 shares, respectively

     (628,216     (488,613

Accumulated other comprehensive income (loss)

     (34,775     (54,074
  

 

 

   

 

 

 

Total Synopsys stockholders’ equity

     4,882,252       4,907,404  

Non-controlling interest

     4,646       4,963  
  

 

 

   

 

 

 

Total stockholders’ equity

     4,886,898       4,912,367  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 8,012,838     $ 8,030,062  
  

 

 

   

 

 

 

 

(1)

Synopsys’ first quarter of fiscal year 2021 ended on January 30, 2021 and its fiscal year 2020 ended on October 31, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.


SYNOPSYS, INC.

Unaudited Consolidated Statements of Cash Flows (1)

(in thousands)

 

     Three Months Ended  
     January 31,  
     2021     2020  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net income attributed to Synopsys

   $ 162,345     $ 104,061  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Amortization and depreciation

     50,628       52,232  

Reduction of operating lease right-of-use assets

     20,974       23,201  

Amortization of capitalized costs to obtain revenue contracts

     15,008       13,762  

Stock-based compensation

     83,782       51,883  

Deferred income taxes

     (20,222     (17,694

Other non-cash

     (3,984     (629

Net changes in operating assets and liabilities, net of acquired assets and liabilities:

    

Accounts receivable

     (7,433     (241,503

Inventories

     (37,139     (5,302

Prepaid and other current assets

     (12,289     8,697  

Other long-term assets

     (50,385     (27,103

Accounts payable and accrued liabilities

     (171,137     (132,814

Operating lease liabilities

     (20,707     (20,979

Income taxes

     12,226       5,039  

Deferred revenue

     152,291       196,969  
  

 

 

   

 

 

 

Net cash provided by operating activities

     173,958       9,820  

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Purchases of long-term investments

     —         (2,500

Purchases of property and equipment

     (27,779     (54,605

Cash paid for acquisitions, net of cash acquired

     (74,670     (75,388

Capitalization of software development costs

     (1,011     (1,065
  

 

 

   

 

 

 

Net cash used in investing activities

     (103,460     (133,558

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Proceeds from credit facilities

     —         196,490  

Repayment of debt

     (5,694     (3,750

Issuances of common stock

     15,092       14,982  

Payments for taxes related to net share settlement of equity awards

     (49,591     (14,242

Purchase of equity forward contract

     (50,000     (20,000

Purchases of treasury stock

     (202,871     (80,000
  

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (293,064     93,480  

Effect of exchange rate changes on cash, cash equivalents and restricted cash

     10,001       2,013  
  

 

 

   

 

 

 

Net change in cash, cash equivalents and restricted cash

     (212,565     (28,245

Cash, cash equivalents and restricted cash, beginning of year

     1,237,970       730,527  
  

 

 

   

 

 

 

Cash, cash equivalents and restricted cash, end of period

   $ 1,025,405     $ 702,282  
  

 

 

   

 

 

 

 

(1)

Synopsys’ first quarter of fiscal year 2021 and 2020 ended on January 30, 2021 and February 1, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.


SYNOPSYS, INC.

Business Segment Reporting (1)

(in millions)

 

     Q1’21     Q1’20  

Revenue by segment

    

- Semiconductor & System Design

   $ 878.3     $ 748.8  

% of Total

     90.5     89.7

- Software Integrity

   $ 92.0     $ 85.6  

% of Total

     9.5     10.3

Total segment revenue

   $ 970.3     $ 834.4  

Adjusted operating income by segment

    

- Semiconductor & System Design

   $ 278.9     $ 178.8  

- Software Integrity

   $ 7.9     $ 8.1  

Total adjusted segment operating income

   $ 286.8     $ 186.9  

Adjusted operating margin by segment

    

- Semiconductor & System Design

     31.8     23.9

- Software Integrity

     8.6     9.4

Total adjusted segment operating margin

     29.6     22.4

Total Adjusted Segment Operating Income Reconciliation (1)(2)

(in millions)

 

     Three Months Ended  
     January 31,
2021 (3)
     January 31,
2020 (3)
 

GAAP total operating income – as reported

   $ 148.3      $ 87.5  

Other expenses managed at consolidated level

     

-Amortization of intangible assets

     20.3        22.5  

-Stock compensation

     83.8        51.9  

-Fair value changes in executive deferred compensation plan

     30.9        12.5  

-Acquisition-related costs

     3.5        3.8  

-Restructuring

     —          8.8  
  

 

 

    

 

 

 

Total adjusted segment operating income

   $ 286.8      $ 186.9  
  

 

 

    

 

 

 

 

(1)

Synopsys manages the business on a long-term, annual basis, and considers quarterly fluctuations of revenue and profitability as normal elements of our business. Amounts may not foot due to rounding.

(2)

These segment results are consistent with the information required by ASC 280, Segment Reporting. They are presented to reflect the information that is considered by Synopsys’ chief operating decision makers (CODMs) to evaluate the operating performance of its segments. The CODMs do not allocate certain operating expenses managed at a consolidated level to our reportable segments, and as a result, the reported operating income and operating margin do not include these unallocated expenses as shown in the table above. Amounts may not foot due to rounding.

(3)

Synopsys’ first quarter of fiscal year 2021 and 2020 ended on January 30, 2021 and February 1, 2020, respectively. For presentation purposes, we refer to the closest calendar month end.